These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 445323)

  • 21. Solid tumor models for the assessment of different treatment modalities: XXIII. A new approach to the more effective utilization of radiotherapy alternated with chemotherapy.
    Looney WB; Hopkins HA; Carter WH
    Int J Radiat Oncol Biol Phys; 1985 Dec; 11(12):2105-17. PubMed ID: 4066443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tumor effects of tumor necrosis factor in combination with chemotherapeutic agents.
    Regenass U; Müller M; Curschellas E; Matter A
    Int J Cancer; 1987 Feb; 39(2):266-73. PubMed ID: 3804497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential recovery of intestine, bone marrow, and thymus of rats with solid tumors following 5-fluorouracil administration.
    Hopkins HA; Kovacs CJ; Looney WB; Wakefield JA
    Cancer Biochem Biophys; 1976; 1(6):303-12. PubMed ID: 189899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid tumor models for the assessment of different treatment modalities: XVI. Sequential combined modality (Cyclophosphamide-Radiation) therapy.
    Looney WB; Ritenour ER; Hopkins HA
    Cancer; 1981 Mar; 47(5):860-9. PubMed ID: 7226039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metastatic breast cancer. Chemotherapy with adriamycin, vindesine, cyclophosphamide and 5 FU. Value of continuous 5 FU perfusion. Results of controlled trials].
    Jouve M; Palangie T; Belli L; Dorval T; Garcia-Giralt E; Beuzeboc P; Scholl S; Mosseri V; Livartowski A; Vedrenne J
    Bull Cancer; 1989; 76(6):643-52. PubMed ID: 2673438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved treatment of a brain-tumor model. Part 2: Sequential therapy with BCNU and 5-fluorouracil.
    Gerosa MA; Dougherty DV; Wilson CB; Rosenblum ML
    J Neurosurg; 1983 Mar; 58(3):368-73. PubMed ID: 6827321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapeutic treatment of the Nb rat adenocarcinoma androgen-insensitive tumor III.
    Drago JR
    J Surg Oncol; 1982 Dec; 21(4):264-6. PubMed ID: 7144207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung.
    Fraile RJ; Samson MK; Baker LH; Talley RW
    Cancer Treat Rep; 1979; 63(11-12):1983-7. PubMed ID: 230896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
    Lokich JJ; Moore CL; Anderson NR
    Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
    O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
    Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours.
    Shibamoto Y; Murata R; Miyauchi S; Hirohashi M; Takagi T; Sasai K; Shibata T; Oya N; Takahashi M
    Br J Cancer; 1996 Dec; 74(11):1709-13. PubMed ID: 8956782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in advanced breast carcinoma.
    Dalley DN; Levi JA; Aroney RS
    Med J Aust; 1980 Mar; 1(5):216-8. PubMed ID: 6990214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
    Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
    Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
    Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR
    Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
    Cancer; 1979 Nov; 44(5):1955-62. PubMed ID: 387212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.